NLM Logo

lazertinib MeSH Supplementary Concept Data 2025


MeSH Supplementary
lazertinib
Unique ID
C000707992
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000707992
Entry Term(s)
2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-
Leclaza
N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide
Pharm Action
Protein Kinase Inhibitors
Registry Numbers
4A2Y23XK11
Heading Mapped to
*Morpholines
*Pyrazoles
*Pyrimidines
Frequency
12
Note
tyrosine kinase inhibitors
Source
Lancet Oncol. 2019 Dec;20(12):1681-1690.
Date of Entry
2020/06/30
Revision Date
2021/10/27
lazertinib Preferred
N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide Broader
Leclaza Narrower
page delivered in 0.004s